191 related articles for article (PubMed ID: 30796910)
1. The Role of Antifibrinolytics in Reducing Blood Loss During Craniofacial or Orthognathic Surgical Procedures: A Meta-Analysis.
Siotou K; Siotos C; Azizi A; Cheah MA; Seal SM; Redett RJ; Rosson GD
J Oral Maxillofac Surg; 2019 Jun; 77(6):1245-1260. PubMed ID: 30796910
[TBL] [Abstract][Full Text] [Related]
2. Safety of antifibrinolytics in cranial vault reconstructive surgery: a report from the pediatric craniofacial collaborative group.
Goobie SM; Cladis FP; Glover CD; Huang H; Reddy SK; Fernandez AM; Zurakowski D; Stricker PA; Gries H;
Paediatr Anaesth; 2017 Mar; 27(3):271-281. PubMed ID: 28211198
[TBL] [Abstract][Full Text] [Related]
3. Safety of antifibrinolytics in 6583 pediatric patients having craniosynostosis surgery: A decade of data reported from the multicenter Pediatric Craniofacial Collaborative Group.
King MR; Staffa SJ; Stricker PA; Pérez-Pradilla C; Nelson O; Benzon HA; Goobie SM;
Paediatr Anaesth; 2022 Dec; 32(12):1339-1346. PubMed ID: 35925835
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
Li G; Sun TW; Luo G; Zhang C
Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
[TBL] [Abstract][Full Text] [Related]
5. The use of antifibrinolytic agents in spine surgery. A meta-analysis.
Gill JB; Chin Y; Levin A; Feng D
J Bone Joint Surg Am; 2008 Nov; 90(11):2399-407. PubMed ID: 18978408
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use.
Basta MN; Stricker PA; Taylor JA
Pediatr Surg Int; 2012 Nov; 28(11):1059-69. PubMed ID: 22940882
[TBL] [Abstract][Full Text] [Related]
7. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytic Agents in Plastic Surgery: Current Practices and Future Directions.
Brown S; Yao A; Taub PJ
Plast Reconstr Surg; 2018 Jun; 141(6):937e-949e. PubMed ID: 29794717
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and utility of antifibrinolytics in pediatric spine surgery: a systematic review and network meta-analysis.
Aghajanian S; Mohammadifard F; Kohandel Gargari O; Naeimi A; Bahadorimonfared A; Elsamadicy AA
Neurosurg Rev; 2024 Apr; 47(1):177. PubMed ID: 38644447
[TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.
Tzortzopoulou A; Cepeda MS; Schumann R; Carr DB
Cochrane Database Syst Rev; 2008 Jul; (3):CD006883. PubMed ID: 18646174
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of prophylactic tranexamic acid versus placebo or no intervention for reducing blood loss in healthy patients undergoing orthognathic surgery: a systematic review protocol.
Baghaie H; Shukla K; Stone J; Breik O; Munn Z
JBI Evid Synth; 2023 Feb; 21(2):430-440. PubMed ID: 36081370
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis.
Cheriyan T; Maier SP; Bianco K; Slobodyanyuk K; Rattenni RN; Lafage V; Schwab FJ; Lonner BS; Errico TJ
Spine J; 2015 Apr; 15(4):752-61. PubMed ID: 25617507
[TBL] [Abstract][Full Text] [Related]
13. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of tranexamic acid for orthognathic surgery: a meta-analysis of randomized controlled trials.
Mei A; Qiu L
Int J Oral Maxillofac Surg; 2019 Oct; 48(10):1323-1328. PubMed ID: 30902548
[TBL] [Abstract][Full Text] [Related]
15. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial.
Verma K; Errico T; Diefenbach C; Hoelscher C; Peters A; Dryer J; Huncke T; Boenigk K; Lonner BS
J Bone Joint Surg Am; 2014 May; 96(10):e80. PubMed ID: 24875032
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive assessment of tranexamic acid during orthognathic surgery: A systematic review and meta-analysis of randomized, controlled trials.
Zhao H; Liu S; Wu Z; Zhao H; Ma C
J Craniomaxillofac Surg; 2019 Apr; 47(4):592-601. PubMed ID: 30826112
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
[TBL] [Abstract][Full Text] [Related]
18. Antifibrinolytic agents for paediatric scoliosis surgery: a systematic review and meta-analysis.
Karimi S; Lu VM; Nambiar M; Phan K; Ambikaipalan A; Mobbs RJ
Eur Spine J; 2019 May; 28(5):1023-1034. PubMed ID: 30739188
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis.
Yuan L; Zeng Y; Chen ZQ; Zhang XL; Mai S; Song P; Tao LY
Chin Med J (Engl); 2019 Mar; 132(5):577-588. PubMed ID: 30807356
[TBL] [Abstract][Full Text] [Related]
20. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis.
Schouten ES; van de Pol AC; Schouten AN; Turner NM; Jansen NJ; Bollen CW
Pediatr Crit Care Med; 2009 Mar; 10(2):182-90. PubMed ID: 19188875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
